Preparation and characterization of lipid vesicles containing uricase

Drug Delivery

Volumn 17, Issue 1, 2010, Pages 28-37

  Tan, Q Y ^a   Wang, N ^b   Yang, H ^c   Chen, L ^a   Xiong, H R ^b   Zhang, L K ^b   Liu, J ^b   Zhao, C J ^b   Zhang, J Q ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Characterization; Enzymatic activity; Lipid esicles; Preparation; Stability; Uricase

Indexed keywords

URATE OXIDASE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; DRUG STABILITY; ENZYME ACTIVITY; ENZYME DEGRADATION; HYPERURICEMIA; LIPID VESICLE; MALE; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; URIC ACID BLOOD LEVEL; ZETA POTENTIAL;

ANIMALS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STORAGE; ENZYME STABILITY; MALE; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; URATE OXIDASE;

EID: 73349112229     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717540903508953     Document Type: Article

References (34)

1. Attwood, P.V., Geeves, M.A. (2002). Changes in catalytic activity and association state of pyruvate carboxylase which are dependent on enzyme concentration. Arch Biochem Biophys. 401:63-72.
2. Bomalaski, J.S., Holtsberg, F.W., Ensor, C.M., Clark, M.A. (2002). Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol. 29:1942-1949.
3. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254
4. Chuang, C.K., Wang, T.J., Yeung, C.Y., Hsieh, W.S., Lin, D.S., Ho, S.C., Lin, S.P. (2006). Interference and blood sample preparation for a pyruvate enzymatic assay. Clin Biochem. 39:74-77
5. Georgiou, C.D., Grintzalis, K., Zervoudakis, G., Papapostolou I. (2008). Mechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteins. Anal Bioanal Chem. 391:391-403.
6. Hashemnia, S., Moosavi-Movahedi, A.A., Ghourchian, H., Ahmad, F., Hakimelahi, G.H., Saboury, A.A. (2006). Diminishing of aggregation for bovine liver catalase through acidic residures modification. Int J Biol Macromol. 40:47-53.
7. Ihler, G., Lantzy, A., Purpura, J., Glew, R.H. (1975). Enzymatic degradation of uric acid by uricase-loaded human erythrocytes. J Clin Invest. 56:595-602.
8. Koppel, D.E. (1972). Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J Chem Phys. 57:4814-4816
9. Kuboi, R., Yoshimoto, M., Walde, P., Luisi, P.L. (1997). Refolding of carbonic anhydrase assisted by 1-palmitoyl-2-oleoyl-sn-glycero-3- phosphocholine liposomes. Biotechnol Prog. 13:828-836
10. Lu, B., Zhang, J., Yang, H. (2003). Nonphospholipid vesicles of carboplatin for lung targeting. Drug Deliv. 10:87-94.
11. Magnani, M., Mancini, U., Bianchi, M., Fazi A. (1992). Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. Adv Exp Med Biol. 326:189-194
12. Mulhbacher, J., McGeeney, K., Ispas-Szabo, P., Lenaerts, V., Mateescu, M.A. (2002). Modified high amylose starch for immobilization of uricase for therapeutic application. Biotechnol Appl Biochem. 36:163-170
13. Nishida, Y., Kamatani, N., Miyamoto, T. (1984). Hypouricaemic effect after oral administration in chichens of poly-ethylene glycolmodified uricase entrapped in liposomes. J Pharm. Pharmacol. 36:354-355
14. Oloughlin, J., Bruder, J., Lysaght, M.J. (2004). Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. ASAIO J. 50:253-260
15. Paust, G., Sergi, M., Veronese, F.M. (2008). Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev. 60:69-78.
16. Poltorak, O.M., Chukhray, E.S., Torshin, I.Y. (1998). Dissociative thermal inactivation, stability, and activity of oligomeric enzymes. Biochemistry. 63:303-311
17. Poznansky, M.J. (1979). In vitro and in vivo activity of soluble crosslinked uricase-albumin polymers: a model for enzyme therapy. Life Sci. 24:153-158
18. Reddy, G.B., Bharadwaj, S., Surolia, A. (1999). Thermal stability and mode of oligomerization of the tetrameric peanut agglutinin: a differential scanning calorimetry study. Biochemistry. 38:4464-4470
19. Rigaud, J.L., Pitard, B., Levy, D. (1995). Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim Biophys Acta. 1231:223-246
20. Sherman, M.R., Saifer, M.G.P., Perezruiz, F. (2008). PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv Drug Deliv Rev. 60:59-68.
21. Sherman, M.R., Saifer, M.G.P., Williams, D. L. (2004). Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates. US Patent 6783965 B1, Mountain View Pharmaceuticals, Inc. and Duke University.
22. Stove, V., Wuyts, B., Delanghe, J. (2007). Perchloric acid treatment to stabilize uric acid concentrations in blood samples of patients receiving uric acid oxidase (rasburicase) therapy. Clin Chem. 15:369-370
23. Torchilin, V.P., Weissig, V. (2003). Liposomes. 2nd ed. Oxford/New York: Oxford University Press, 231-265
24. Walde, P., Ichikawa, S. (2001). Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomolec Eng. 18:143-177
25. Xu, L., Shi, L. (2008). Establishment of hyperuricemia rat model with different doses of hypoxanthine and oxonic acid postassium salt. Chin J Pharmacol Toxicol. 22:306-310
26. Yasuda, Y., Fujita, T., Takakura, Y., Hashida, M., Sezaki, H. (1990). Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol. Chem Pharm Bull. 38:2053-2056
27. Yoshimoto, M., Satkmoto, H., Yoshimoto, N. (2007). Stabilization of quaternary structure and activity of bovine liver catalase through encapsulation in liposomes. Enzyme Microbial Tech. 41:849-858
28. Yoshimoto, M., Wang, S., Fukunaga, K., Treyer, M., Walde, P., Kuboi, R., Nakao, K. (2004). Enhancement of apparent substrate selectivity of proteinase K encapsulated in liposomes through a cholate-induced alteration of the bilayer permeability. Biotechnol Bioeng. 85:222-233
29. Yoshimoto, M., Wang, S., Fukunaga, K., Walde, P., Kuboi, R., Nakao, K. (2005). Novel immobilized liposomal glucose oxidase system using the channel protein ompf and catalase. Biotechnol Bioeng. 90:231-238
30. Zhang, J.Q., Liu, J., Li, X.L., Jasti, B.R. (2007). Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 14:381-387
31. Zhang, J.Q., Zhang, Z.R., Yang, H., Tan, Q.Y., Qin, S.R., Qiu, X.L. (2005). Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm Res. 22:573-583
32. Zhao, Y.S., Yang, X.L., Lu, W., Liao, H., Liao, F. (2009a). Uricase based methods for determination of uric acid in serum. Microchim Acta. 164:1-6.
33. Zhao, Y.S., Yang, X.L., Li, X.Y., Bu, Y., Deng, P., Zhang, C., Feng, J., Xie, Y., Zhu, S., Yuan, H., Yu, M., Liao, F. (2009b). Reversible inactivation of an intracellular uricase from Bacillus fastidiosus via dissociation of homotetramer into homodimers in solutions of low ionic strength. Biosci Biotechnol Biochem. 73:2141-2144
34. Zhao, Y.S., Zhao, L., Yang, G.Q., Tao, J., Bu, Y.Q., Liao, F. (2006). Characterization of uricase from bacillus fastidious A.T.C.C. 26904 and its application to serum uric acid assay by a patented kinetic uricase method. Biotechnol Appl Biochem. 45:75-80.